SGN-30 (Anti-CD30 monoclonal antibody) is active and well tolerated in patients with refractory or recurrent systemic anaplastic large cell lymphoma (ALCL)

Forero-Torres, A; Bernstein, SH; Gopal, AK; Foss, F; Leonard, JP; Rosenblatt, JD; Bartlett, NL; Cheson, BD; Epner, E; Hernandez-Illizaliturri, FJ; Proctor, SJ; Brice, P; Tilly, H; Haioun, C; Jerkeman, M; Bosly, A; Lorenz, JM; Barton, J

SGN-30 (Anti-CD30 monoclonal antibody) is active and well tolerated in patients with refractory or recurrent systemic anaplastic large cell lymphoma (ALCL)

Lookup NU author(s): Professor Stephen Proctor

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Forero-Torres A, Bernstein SH, Gopal AK, Foss F, Leonard JP, Rosenblatt JD, Bartlett NL, Cheson BD, Epner E, Hernandez-Illizaliturri FJ, Proctor SJ, Brice P, Tilly H, Haioun C, Jerkeman M, Bosly A, Lorenz JM, Barton J

Publication type: Article

Publication status: Published

Journal: Blood

Year: 2005

Volume: 106

Issue: 11

Pages: 938A-938A

ISSN (print): 0006-4971

ISSN (electronic): 1528-0020

Notes: Conference: 47th Annual Meeting of the American Society of Hematology, Atlanta, GA, 10-13 December 2005. Abstract 3356

ePrints

SGN-30 (Anti-CD30 monoclonal antibody) is active and well tolerated in patients with refractory or recurrent systemic anaplastic large cell lymphoma (ALCL)

Downloads

Publication metadata

Share